More importantly, the overall survival of primary recipients receiving Asic3-null leukemia cells, but not Asic1a-null cells, was significantly reduced (Figure 1D and Supplemental Figure 1M), indicating that ASIC3 may suppress leukemogenesis. Here, ASIC3 is linked to leukemia.